Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
This comparison outlines 2024 tax treatment differences between dividends from ETFs and mutual funds for informed decisions.
24,763 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Iran tensions and hawkish policy signals are lifting yields, putting mortgage rates breaking higher and spring housin...
Unisys (UIS) 2026 earnings could hinge on services growth, margin discipline, and backlog strength. This guide breaks...
Alibaba's latest earnings mix puts cloud momentum in the spotlight while profitability falters. This article untangle...
NVIDIA posted a blowout quarter as AI demand drives data-center growth, fueling bets that the company will form trill...
Nvidia sits at a pivotal crossroads as driverless technology could next reshape how auto tech and AI collide. This ar...
iQIYI is betting on AI to revive growth as its core subscription business falters. With Nadou Pro signing thousands o...
Dell Technologies leads the pack in 2026 among AI server stocks, outpacing Hewlett Packard Enterprise and Super Micro...
A softer-than-expected June jobs report is loosening the grip of Wall Street’s momentum trade, prompting bets on limi...
As the 2027 COLA comes into view, rising Medicare premiums threaten to erode any gains for many seniors. Here's what ...
Mativ's 2025 earnings cycle reveals a company navigating macro headwinds with disciplined execution. This article bre...
Zscaler's Q2 2026 earnings signal exciting momentum across its three growth pillars. This article breaks down the dri...